Gene · 4923
Papers2,119
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,119
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcription profiling of feline mammary carcinomas and derived cell lines reveals biomarkers and drug targets associated with metabolic and cell cycle pathways. | Sci Rep | 2022 | 36220861 | PubTator, text mining | PubMed |
| SWEET13 transport of sucrose, but not gibberellin, restores male fertility in Arabidopsis sweet13;14. | Proc Natl Acad Sci U S A | 2022 | 36215460 | PubTator, text mining | PubMed |
| Extending the Stochastic Titration CpHMD to CHARMM36m. | J Phys Chem B | 2022 | 36190807 | PubTator, text mining | PubMed |
| Activation of CCL21-GPR174/CCR7 on cardiac fibroblasts underlies myocardial ischemia/reperfusion injury. | Front Genet | 2022 | 36159993 | PubTator, text mining | PubMed |
| Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2022 | 36139627 | PubTator, text mining | PubMed |
| Computational Insights into the Sequence-Activity Relationships of the NGF(1-14) Peptide by Molecular Dynamics Simulations. | Cells | 2022 | 36139382 | PubTator, text mining | PubMed |
| The Role of Disordered Regions in Orchestrating the Properties of Multidomain Proteins: The SARS-CoV-2 Nucleocapsid Protein and Its Interaction with Enoxaparin. | Biomolecules | 2022 | 36139141 | PubTator, text mining | PubMed |
| Structure of the active Gi-coupled human lysophosphatidic acid receptor 1 complexed with a potent agonist. | Nat Commun | 2022 | 36109516 | PubTator, text mining | PubMed |
| Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD. | Neuron | 2022 | 36087581 | PubTator, text mining | PubMed |
| Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumors. | Sci Rep | 2022 | 36056076 | PubTator, text mining | PubMed |
| Nitroreduction: A Critical Metabolic Pathway for Drugs, Environmental Pollutants, and Explosives. | Chem Res Toxicol | 2022 | 36044734 | PubTator, text mining | PubMed |
| Transcriptome analysis of well-differentiated laryngeal squamous cell carcinoma cells in below-background environment. | Ann Transl Med | 2022 | 36035002 | PubTator, text mining | PubMed |
| Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges. | Molecules | 2022 | 36014472 | PubTator, text mining | PubMed |
| Dynamin-Independent Mechanisms of Endocytosis and Receptor Trafficking. | Cells | 2022 | 36010634 | PubTator, text mining | PubMed |
| Detergent-Free Isolation of Membrane Proteins and Strategies to Study Them in a Near-Native Membrane Environment. | Biomolecules | 2022 | 36008970 | PubTator, text mining | PubMed |
| A genome-wide association study of total child psychiatric problems scores. | PLoS One | 2022 | 35994476 | PubTator, text mining | PubMed |
| Achondroplasia in Latin America: practical recommendations for the multidisciplinary care of pediatric patients. | BMC Pediatr | 2022 | 35986266 | PubTator, text mining | PubMed |
| The Orexin receptors: Structural and anti-tumoral properties. | Front Endocrinol (Lausanne) | 2022 | 35966051 | PubTator, text mining | PubMed |
| Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing. | J Transl Med | 2022 | 35962453 | PubTator, text mining | PubMed |
| Metabolic Pathways as a Novel Landscape in Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2022 | 35954462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4923/papers?page=18